RETAVASE
Boehringer Mannheim Pharmaceuticals Corporation
| Research |
OneLook
Acronym Finder
|
| Serial Number | 74647641 |
| Mark Drawing Code | 1000: Typeset: Word(s)/letter(s)/number(s) |
| Attorney Name | Max J. Kenemore |
| Law Office Assigned | L50 |
| Employee Name | SNAPP, TINA LOUISE |
Timeline
| 1995-03-16 | Application Filed |
| 1995-10-17 | Published for Opposition |
| 1997-03-20 | Abandon |
| 1997-11-12 | Status: Dead/Abandoned |
| 1998-01-12 | Location: FILE REPOSITORY (FRANCONIA) |
| 2018-07-08 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  BOEHRINGER MANNHEIM PHARMACEUTICALS CORPORATION |
| Address | 101 Orchard Ridge Drive Gaithersburg DE 20878 |
| Legal Entity Type | Corporation |
| Legal Entity State | DE |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| GS0051 | cardiovascular agent, namely a recombinant plasminogen activator compound, for use in the management of acute myocardial infarction |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| ASSIGNED TO EXAMINER | 1995-08-03 | 1 DOCK D:Assigned to Examiner |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 1995-08-04 | 2 CNSA P: |
| NOTICE OF PUBLICATION | 1995-09-15 | 3 NPUB O:Outgoing Correspondence |
| PUBLISHED FOR OPPOSITION | 1995-10-17 | 4 PUBO A:Allowance for Publication |
| NOA MAILED - SOU REQUIRED FROM APPLICANT | 1996-03-19 | 5 NOAM O:Outgoing Correspondence |
| ABANDONMENT - NO USE STATEMENT FILED | 1997-03-20 | 6 ABN6 S: |
| PETITION TO REVIVE-RECEIVED | 1997-08-01 | 7 PETR I:Incoming Correspondence |
| PETITION TO REVIVE-DENIED | 1997-11-07 | 8 PETD O:Outgoing Correspondence |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 RETAVASE 88341695 not registered Live/Pending |
EKR THERAPEUTICS, INC. 2019-03-15 |
 RETAVASE 75324869 2175074 Dead/Cancelled |
EKR THERAPEUTICS, INC. 1997-07-15 |
 RETAVASE 74647641 not registered Dead/Abandoned |
BOEHRINGER MANNHEIM PHARMACEUTICALS CORPORATION 1995-03-16 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 